|
Fractional exhaled nitric oxygen in asthma patients |
Mengarelli C, Bardach A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Ciapponi A, López A, Rey-Ares L |
|
|
Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Mengarelli C, Bardach A, Pichon-Riviere A, Augustovski F, García Martí S, Alcaraz A, Ciapponi A, López A, Rey-Ares L. Fractional exhaled nitric oxygen in asthma patients. Buenos Aires: Institute for Clinical Effectiveness and Health Policy (IECS). Informe de Respuesta Rapida No. 494. 2016 Authors' conclusions Evidence of low methodological quality suggests that fractional exhaled nitric oxide to monitor glucocorticoid therapy in adult asthma patients might reduce the number of exacerbations, while the evidence in pediatric patients is not enough. When comparing the clinical assessment (with or without spirometry) in treatment monitoring, the exhaled fraction might have moderate sensitivity and specificity.
Most of the clinical practice guidelines identified do not recommend its use.
Some United States private sponsors cover the test while others consider it at experimental stage.
Final publication URL www.iecs.org.ar Indexing Status Subject indexing assigned by CRD MeSH Asthma; Breath Tests; Exhalation; Humans; Oxygen Language Published Spanish Country of organisation Argentina English summary An English language summary is available. Address for correspondence Institute for Clinical Effectiveness and Health Policy, Viamonte 2146 - 3 Piso, C1056ABH Ciudad de Buenos Aires, Argentina Tel: +54 11 49 66 00 82 Fax:+54 11 49 53 40 58 Email: info@iecs.org.ar AccessionNumber 32016001114 Date abstract record published 25/11/2016 |
|
|
|